1. The long non-coding RNA ZFAS1 promotes colorectal cancer progression via miR200b/ZEB1 axis
    Islam T. Salman et al, 2023, Pathology - Research and Practice CrossRef
  2. Does insulin make breast cancer cells resistant to doxorubicin toxicity?
    Oleksandra Lykhova et al, 2023, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
  3. MiRNA Profiling and Its Potential Roles in Rapid Growth of Velvet Antler in Gansu Red Deer (Cervus elaphus kansuensis)
    Zhenxiang Zhang et al, 2023, Genes CrossRef
  4. Noxa inhibits oncogenesis through ZNF519 in gastric cancer and is suppressed by hsa-miR-200b-3p
    Jin Shi et al, 2024, Scientific Reports CrossRef
  5. Differential levels of circulating RNAs prior to endometrial cancer diagnosis
    Sina Rostami et al, 2024, International Journal of Cancer CrossRef
  6. Microenvironment commits breast tumor ECs to dedifferentiation by micro-RNA-200-b-3p regulation and extracellular matrix remodeling
    Kinga Wilkus-Adamczyk et al, 2023, Frontiers in Cell and Developmental Biology CrossRef
  7. A comprehensive integrated gene network construction to explore the essential role of Notch 1 in lung adenocarcinoma (LUAD)
    Pearl John et al, 2024, Journal of Biomolecular Structure and Dynamics CrossRef
  8. miR 31-3p Has the Highest Expression in Cesarean Scar Endometriosis
    Maria Szubert et al, 2022, International Journal of Molecular Sciences CrossRef
  9. miR-200b, ZEB2 and PTPN13 Are Downregulated in Colorectal Carcinoma with Serosal Invasion
    Branislava Ranković et al, 2022, Biomedicines CrossRef
  10. Why are squamous cancers so aggressive in recessive dystrophic epidermolysis bullosa? Can we find new therapeutic approaches?
    Ryan F L O’Shaughnessy, 2023, British Journal of Dermatology CrossRef
  11. Unraveling the Role of miR-200b-3p in Attention-Deficit/Hyperactivity Disorder (ADHD) and Its Therapeutic Potential in Spontaneously Hypertensive Rats (SHR)
    Tung-Ming Chang et al, 2024, Biomedicines CrossRef
  12. Potential of the miR-200 Family as a Target for Developing Anti-Cancer Therapeutics
    Hyein Jo et al, 2022, International Journal of Molecular Sciences CrossRef